
|Videos|September 28, 2011
Dr. Burtness on the Head and Neck Symposium Design
Author(s)Barbara Burtness, MD
Dr. Barbara Burtness from Fox Chase Cancer Center on the Head and Neck Symposium Design
Advertisement
Barbara Burtness, MD, Chief, head and neck medical oncology, co-leader, developmental therapeutics, Fox Chase Cancer Center, discusses how the 7th Annual Multidisciplinary Symposium on Head and Neck Cancer was designed around the unique nature of head and neck cancer.
The radiation, surgical, and medical oncologist will evaluate each patient treated for head and neck cancer. The speakers, topics, and those in attendance will represent these multiple disciplines.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on OncLive
1
Single-Center, Retrospective Data Show Low Rate of Lifileucel Infusion Following Referral in Advanced Melanoma
2
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
3
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
4
Dr Riedell on the Long-Term Efficacy of Tisa-Cel in R/R Follicular Lymphoma
5






































